河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (12): 1386-1392.doi: 10.3969/j.issn.1007-3205.2023.12.004

• • 上一篇    下一篇

miR-130b-3p在肾癌中表达及PI3K/AKT途径参与的机制研究

  

  1. 河北工程大学附属医院泌尿外二科,河北 邯郸 056002

  • 出版日期:2024-01-02 发布日期:2024-01-02
  • 作者简介:谭超(1992-),男,河北邯郸人,河北工程大学附属医院主治医师,医学硕士,从事泌尿系肿瘤疾病诊治研究。
  • 基金资助:
    邯郸市科学技术与研究发展项目(19422083011-13)

Expression of miR-130b-3p in renal cell carcinoma and the mechanism of PI3K/AKT pathway involvement

  1. The Second Department of Urology, the Affiliated Hospital of Hebei University of Technology, Handan 056002, China

  • Online:2024-01-02 Published:2024-01-02

摘要: 目的 探究miR-130b-3p调节PI3K/AKT途径对肾癌细胞生物学行为的影响及作用机制。 
方法 临床收集肾癌患者78例,检测肿瘤组织和癌旁组织中miR-130b-3p和PTEN蛋白水平,分析miR-130b-3p与肾癌病理特征的关系。通过相关性分析探究肾癌组织中miR-130b-3p与PTEN蛋白的相关性。786-O细胞分为NC、miR-130b-3p、PTEN和miR-130b-3p+PTEN组,分别转染NC、miR-130b-3p mimic和/或pcDNA 3.1 PTEN来过表达miR-130b-3p和/或PTEN。分别检测各组细胞活力、凋亡率、侵袭能力以及PI3K/AKT通路水平。
结果 肾癌组织中miR-130b-3p水平显著高于癌旁组织(P<0.05)。miR-130b-3p表达水平与性别、年龄、肿瘤直径无关,高水平的miR-130b-3p与高临床分期和淋巴转移有关(P<0.05)。miR-130b-3p与PTEN靶向结合(P<0.05)。与NC组比较,miR-130b-3p组的PTEN蛋白和凋亡率显著降低,增殖活力、侵袭能力和PI3K/AKT通路显著升高(P<0.05);PTEN组的PTEN蛋白和凋亡率显著升高,增殖活力、侵袭能力和PI3K/AKT通路显著抑制(P<0.05)。miR-130b-3p+PTEN组的PTEN蛋白和凋亡率显著高于miR-130b-3p组且显著低于PTEN组,而增殖活力、侵袭能力和PI3K/AKT通路显著低于miR-130b-3p组且显著高于PTEN组(P<0.05)。 
结论 miR-130b-3p在肾癌组织中上调,高水平的miR-130b-3p与肾癌患者的高临床分期和转移有关,miR-130b-3p可调控PI3K/AKT途径,抑制PTEN蛋白表达,促进肾癌细胞的侵袭并抑制凋亡。


关键词: 肾肿瘤, 微小RNA, miR-130b-3p

Abstract: Objective To explore the effect and mechanism of miR-130b-3p regulating PI3K/AKT pathway on the biological behavior of renal cancer cells. 
Methods A total of 78 renal cancer patients were clinically selected. The protein levels of miR-130b-3p and PTEN in tumor tissues and adjacent tissues were detected, and the relationship between miR-130b-3p and pathological features of renal cancer was analyzed. The correlation between miR-130b-3p and PTEN protein in renal cancer tissue was explored by correlation analysis. 786-O cells were divided into negative control (NC) group, miR-130b-3p, PTEN and miR-130b-3p+PTEN groups. NC, miR-130b-3p mimic and/or pcDNA 3.1 PTEN were transfected to overexpress miR-130b-3p and/or PTEN, respectively. The cell viability, apoptosis rate, invasion ability and PI3K/AKT pathway level in each group were detected respectively. 
Results The level of miR-130b-3p in renal cancer tissues was significantly higher than that in adjacent tissues (P<0.05). The expression level of miR-130b-3p was independent of gender, age and tumor diameter. High level of miR-130b-3p was associated with high clinical stage and lymphatic metastasis (P<0.05), with miR-130b-3p targeted binding to PTEN (P<0.05). Compared with the NC group, the PTEN protein and apoptosis rate of the miR-130b-3p group were significantly decreased, and the proliferation activity, invasion ability and PI3K/AKT pathway were significantly increased (P<0.05). In the PTEN group, the PTEN protein and apoptosis rate were significantly increased, while the proliferation activity, invasion ability and PI3K/AKT pathway were significantly inhibited (P<0.05). The PTEN protein and apoptosis rate of the miR-130b-3p+PTEN group were significantly higher than those of the miR-130b-3p group and significantly lower than those of the PTEN group, while the proliferation activity, invasion ability and PI3K/AKT pathway were significantly lower than those of the miR-130b-3p group, and significantly higher than those of the PTEN group (P<0.05). 
Conclusion miR-130b-3p is upregulated in renal cancer tissues, and high levels of miR-130b-3p are associated with high clinical stage and metastasis in renal cancer patients. miR-130b-3p can regulate PI3K/AKT pathway, inhibit the expression of PTEN protein, promote the invasion of renal cell carcinoma cells and inhibit apoptosis. 


Key words: kidney neoplasms, microRNA, miR-130b-3p